AI assistant
CYTOKINETICS INC — Director's Dealing 2011
Nov 21, 2011
30870_dirs_2011-11-21_f6236104-a933-49d0-aaca-bb98bec0f2d8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2011-11-17
Reporting Person: WOLFF ANDREW A (SVP Clinical R&D, CMO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-17 | Restricted Stock Units | $ | A | 175000 | Acquired | Common Stock (175000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 10000 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $1.57 | 2021-02-28 | Common Stock (58336) | 58336 | Direct |
| Incentive Stock Option (right to buy) | $1.85 | 2019-02-26 | Common Stock (37917) | 37917 | Direct |
| Incentive Stock Option (right to buy) | $3.08 | 2020-02-24 | Common Stock (42084) | 42084 | Direct |
| Incentive Stock Option (right to buy) | $3.37 | 2018-02-28 | Common Stock (27935) | 27935 | Direct |
| Incentive Stock Option (right to buy) | $6.59 | 2015-04-11 | Common Stock (781) | 781 | Direct |
| Incentive Stock Option (right to buy) | $6.81 | 2017-03-14 | Common Stock (14185) | 14185 | Direct |
| Incentive Stock Option (right to buy) | $7.15 | 2016-03-01 | Common Stock (17019) | 17019 | Direct |
| Incentive Stock Option (right to buy) | $9.91 | 2014-10-20 | Common Stock (40360) | 40360 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.57 | 2021-02-28 | Common Stock (141664) | 141664 | Direct |
| Non-Qualified Stock Option (right to buy) | $1.85 | 2019-02-26 | Common Stock (92083) | 92083 | Direct |
| Non-Qualified Stock Option (right to buy) | $3.08 | 2020-02-24 | Common Stock (92916) | 92916 | Direct |
| Non-Qualified Stock Option (right to buy) | $3.37 | 2018-02-28 | Common Stock (97065) | 97065 | Direct |
| Non-Qualified Stock Option (right to buy) | $6.59 | 2015-04-11 | Common Stock (11719) | 11719 | Direct |
| Non-Qualified Stock Option (right to buy) | $6.81 | 2017-03-14 | Common Stock (40815) | 40815 | Direct |
| Non-Qualified Stock Option (right to buy) | $7.15 | 2016-03-01 | Common Stock (42981) | 42981 | Direct |
| Non-Qualified Stock Option (right to buy) | $9.91 | 2014-10-20 | Common Stock (69640) | 69640 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of CYTK common stock.
F2: The restricted stock units vest in two equal annual installments. Vested shares will be delivered to the reporting person on 9/4/2012 and 9/3/2013.
F3: When the ISO and NQ dated 02/28/2011 are combined for a total grant of 200,000 shares, the option shall vest and become exercisable as to 4,166 shares on 03/31/2011 and the balance of 195,834 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/28/2015.
F4: When the ISO and NQ dated 02/26/2009 are combined for a total grant of 130,000 shares, the option shall vest and become exercisable as to 2,708 shares on 03/26/09 and the balance of 127,292 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/26/13.
F5: When the ISO and NQ dated 02/24/2010 are combined for a total grant of 135,000 shares, the option shall vest and become exercisable as to 2,812 shares on 03/24/2010 and the balance of 132,188 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/24/2014.
F6: When the ISO and NQ dated 02/29/2008 are combined for a total grant of 125,000 shares, the option shall vest and become exercisable as to 2,604 shares on 03/29/08 and the balance of 122,396 divided into equal monthly installments thereafter such that the option shall be 100% vested on 02/29/12.
F7: When the ISO and NQ dated 04/11/05 are combined for a total grant of 12,500 shares, the option shall vest and become exercisable as to 12,500 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2009.
F8: When the ISO and NQ dated 03/14/2007 are combined for a total grant of 55,000 shares, the option shall vest and become exercisable as to 1,146 shares on 04/01/07 and the balance of 53,854 divided into equal monthly installments thereafter such that the option shall be 100% vested on 03/01/11.
F9: When the ISO and NQ dated 03/01/2006 are combined for a total grant of 60,000 shares, the option shall vest and become exercisable as to 60,000 shares divided into equal monthly installments such that the option shall be 100% vested on 03/01/2010.
F10: When the ISO and NQ dated 10/20/04 are combined for a total grant of 110,000 shares, the option shall vest and become exercisable as to 27,500 shares on 09/20/05 and the balance of 82,500 divided into equal monthly installments thereafter such that the option shall be 100% vested on 09/20/08.